Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gavras

Showing results (291-300 of 312) with videos related to

Pageof 32
Sort By:
American Journal of Hypertension|July 10, 1998
Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy: effects on LVH regression and arrhythmogenic propensityA J Manolis, D Beldekos, S Handanis, et al.
Clinical Genetics|September 5, 2001
Maternal component in the familial aggregation of hypertensionA L DeStefano, H Gavras, N Heard-Costa, et al.
American Heart Journal|March 1, 1975
Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and manH Gavras, D Kremer, J J Brown, et al.
Journal of Clinical Pharmacology|February 1, 1979
Effect of nadolol in treatment of hypertensionL Volicer, C S Liang, H Gavras, et al.
American Journal of Hypertension|September 1, 1993
Contribution of vasopressin to orthostatic blood pressure maintenance in essential hypertensionR B de Paula, F L Plavnik, C I Rodrigues, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1995
Role of bradykinin in insulin sensitivity and blood pressure regulation during hyperinsulinemiaO Kohlman, F de A Neves, M Ginoza, et al.
Annals of the New York Academy of Sciences|July 22, 1993
Age and race determine vasopressin participation in upright blood pressure control in essential hypertensionR B De Paula, F L Plavnik, C I Rodrigues, et al.
Hypertension (Dallas, Tex. : 1979)|July 16, 1999
Evidence for linkage between essential hypertension and a putative locus on human chromosome 17J Baima, M Nicolaou, F Schwartz, et al.
The New England Journal of Medicine|May 4, 1978
Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in manH Gavras, H R Brunner, G A Turini, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1995
Cardiovascular effects of a specific nonpeptide antagonist of substance P (NK-1) receptor in DOCA-salt hypertensionO Kohlmann, M Ginoza, M L Cezaretti, et al.
Pageof 32

Showing results (291-300 of 312) with videos related to

Sort By:
Pageof 32
American Journal of Hypertension|July 10, 1998
Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy: effects on LVH regression and arrhythmogenic propensityA J Manolis, D Beldekos, S Handanis, et al.
Clinical Genetics|September 5, 2001
Maternal component in the familial aggregation of hypertensionA L DeStefano, H Gavras, N Heard-Costa, et al.
American Heart Journal|March 1, 1975
Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and manH Gavras, D Kremer, J J Brown, et al.
Journal of Clinical Pharmacology|February 1, 1979
Effect of nadolol in treatment of hypertensionL Volicer, C S Liang, H Gavras, et al.
American Journal of Hypertension|September 1, 1993
Contribution of vasopressin to orthostatic blood pressure maintenance in essential hypertensionR B de Paula, F L Plavnik, C I Rodrigues, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1995
Role of bradykinin in insulin sensitivity and blood pressure regulation during hyperinsulinemiaO Kohlman, F de A Neves, M Ginoza, et al.
Annals of the New York Academy of Sciences|July 22, 1993
Age and race determine vasopressin participation in upright blood pressure control in essential hypertensionR B De Paula, F L Plavnik, C I Rodrigues, et al.
Hypertension (Dallas, Tex. : 1979)|July 16, 1999
Evidence for linkage between essential hypertension and a putative locus on human chromosome 17J Baima, M Nicolaou, F Schwartz, et al.
The New England Journal of Medicine|May 4, 1978
Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in manH Gavras, H R Brunner, G A Turini, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1995
Cardiovascular effects of a specific nonpeptide antagonist of substance P (NK-1) receptor in DOCA-salt hypertensionO Kohlmann, M Ginoza, M L Cezaretti, et al.
Pageof 32